Nanotechnology Characterization Laboratory
The Nanotechnology Characterization Laboratory provides comprehensive preclinical characterization of nanomedicine formulations, encompassing physicochemical characterization as well as in vitro and in vivo immunology, pharmacology and toxicology evaluation.
The laboratory has characterized hundreds of unique nanomedicine formulations and has experience with most nanotechnology platforms, active pharmaceutical ingredients and other strategies being explored for nanotech drug development.
There are several mechanisms available for collaboration, including:
- The free Assay Cascade characterization program
- Fee-based research and development collaborations
- Purchase of select fee-for-service assays through the Technical Services program
The Nanotechnology Characterization Laboratory also provides a host of other resources for nanotech developers, including:
- Free consultation on experimental design or strategy
- An expansive library of protocols developed for the physical, chemical and biological study of nanomedicines
For more information on the services and resources available, visit the National Cancer Institute's website.
Nanomedicines and Nanoformulation
Assay Cascade: Preclinical nanotechnology characterization
The Nanotechnology Characterization Laboratory Assay Cascade is a free characterization program available to any researcher creating a nano-product for cancer. Accepted applicants will have their nanomedicine formulation characterized for physicochemical traits, and immunology, pharmacology and toxicology properties.
Who can request the service
The program is open to developers focused on oncology from academia, industry, and government. Applicants from non-U.S. organizations are welcome to apply. This service is funded by the National Cancer Institute.
Applications are accepted year-round with quarterly deadlines the first business days of March, June, September and December.
Nanotechnology research and development projects
Various research and development projects can be supported, including:
- Formulation, Optimization, Lead Selection
- Mechanistic Studies
- Characterization of Non-Oncology Nanomaterials
- Bioanalytical Assay Development
- Instrument Optimization
- And more
Who can request the service
These projects are open to all nanotech developers. All research and development projects must be fully funded by the submitting investigator.
How to apply
Contact us for more information or to discuss a potential project.
Work is initiated through negotiated Contractor Cooperative Research and Development Agreements (cCRADAs), which are organized through our Partnership Development Office.
- An in vitro drug release study in human plasma Technical Service FNL Technical Service Number: NCL-01
- Pharmacokinetic study of nanomedicine in rats Technical Service FNL Technical Service Number: NCL-02